Peritoneal Metastasis
Showing 1 - 25 of 3,576
Postoperative Peritoneal Metastasis After Hepatocellular
Completed
- Peritoneal Metastasis
- Peritoneal Metastasis
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Oct 25, 2023
The PIPAC PET Pilot Study, OPC-7
Not yet recruiting
- Peritoneal Cancer
- +3 more
- scan
- (no location specified)
Nov 17, 2023
Gastric Cancer Trial (HIPEC,anti-PD-1 antibody Sintilimab (Tyvyt®), Chemotherapy,Surgery)
Not yet recruiting
- Gastric Cancer
- HIPEC,anti-PD-1 antibody Sintilimab (Tyvyt®), Chemotherapy,Surgery
- (no location specified)
Dec 14, 2022
HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With
Not yet recruiting
- Gastric Cancer
- Observational
- (no location specified)
Dec 13, 2022
Peritoneal Metastasis for Gastric Cancer Based on Radiomics
Recruiting
- Gastric Cancer
- Peritoneal Metastases
- Peritoneal metastasis status ascertainment
-
Beijing, China
- +12 more
Feb 12, 2023
Hepatocellular Carcinoma, Peritoneal Metastasis, Hyperthymic Trial in Chengdu (mitomycin C-based hyperthermic intraperitoneal
Recruiting
- Hepatocellular Carcinoma
- +3 more
- mitomycin C-based hyperthermic intraperitoneal chemotherapy
-
Chengdu, Sichuan, ChinaWest China Hospital
Sep 14, 2022
Peritoneal Metastases Trial in Ramat Gan (Allocetra-OTS)
Not yet recruiting
- Peritoneal Metastases
-
Ramat Gan, IsraelThe Chaim Sheba Medical Center
Jun 22, 2022
Gastric Cancer With Peritoneal Metastasis (PCI<12) Trial in Seoul (CRS+HIPEC)
Recruiting
- Gastric Cancer With Peritoneal Metastasis (PCI<12)
-
Seoul, Korea, Republic ofDepartment of Surgery, Yonsei University College of Medicine
Apr 21, 2022
Stage IV Gastric Cancer With Metastasis Trial (Camrelizumab; Nab-paclitaxel; S-1)
Not yet recruiting
- Stage IV Gastric Cancer With Metastasis
- Camrelizumab; Nab-paclitaxel; S-1
- (no location specified)
Jul 5, 2022
Role of PET/CT in Peritoneal Deposits Assessment
Not yet recruiting
- Peritoneal Metastases
- PET/CT
- (no location specified)
Nov 14, 2023
Peritoneal Metastasis of Gastric Cancer by Liquid Biopsy in
Recruiting
- Cancer
- Baseline blood draw and blood-based biomarkers analyses
-
Shanghai, Shanghai, ChinaZhongShan Hospital, Fudan university, Shanghai, China
Apr 21, 2022
Metastatic Pancreatic Carcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Rochester (Cisplatin, Hyperthermic Intraperitoneal
Not yet recruiting
- Metastatic Pancreatic Carcinoma
- Stage IV Pancreatic Cancer AJCC v8
- Cisplatin
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 6, 2023
Gastric Cancer Stage IV, Peritoneal Metastases Trial in Shanghai (sintilimab, paclitaxel and S-1)
Recruiting
- Gastric Cancer Stage IV
- Peritoneal Metastases
- sintilimab, paclitaxel and S-1
-
Shanghai, Shanghai, ChinaRuijin Hospital Shanghai Jiao Tong University School of Medicine
Jan 10, 2022
Peritoneal Metastases From Colorectal Cancer Trial in Milano (Patient-tailored hyperthermic intraperitoneal chemo (HIPEC))
Recruiting
- Peritoneal Metastases From Colorectal Cancer
- Patient-tailored hyperthermic intraperitoneal chemotherapy (HIPEC)
-
Milano, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Sep 26, 2023
Pancreatic Tumor Trial in Shanghai (intraperitoneal (IP) Cisplatin combined with intravenous gemcitabine + nab-paclitaxel)
Recruiting
- Pancreatic Neoplasm
- intraperitoneal (IP) Cisplatin combined with intravenous gemcitabine + nab-paclitaxel
-
Shanghai, Shanghai, China
- +1 more
Feb 2, 2022
Peritoneal Metastases From Colorectal Cancer Trial in Milano (Pressurized intraperitoneal aerosol chemo (PIPAC))
Recruiting
- Peritoneal Metastases From Colorectal Cancer
- Pressurized intraperitoneal aerosol chemotherapy (PIPAC)
-
Milano, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Oct 16, 2023
Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (Docetaxel,
Recruiting
- Metastatic Gastric Adenocarcinoma
- Metastatic Gastroesophageal Junction Adenocarcinoma
- Docetaxel
- +2 more
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated hosipital, Sun Yat-Sen University
Jan 20, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Metastatic Malignant Tumor in the Peritoneum Trial in
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- Biospecimen Collection
- +8 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Mar 2, 2023
Stomach Tumors, Peritoneal Metastases Trial (HIPEC, Paclitaxel-albumin, Tegafur-gimeracil-oteracil potassium)
Not yet recruiting
- Stomach Neoplasms
- Peritoneal Metastases
- HIPEC
- +3 more
- (no location specified)
Oct 26, 2021
Unresectable Colon Cancer Peritoneal Metastases, PMMR/Ras/BRAF Wild-type Trial in Huzhou (Serplulimab Combined With FOLFIRI and
Recruiting
- Unresectable Colon Cancer Peritoneal Metastases
- PMMR/Ras/BRAF Wild-type
- Serplulimab Combined With FOLFIRI and Bevacizumab
-
Huzhou, Zhejiang, ChinaChangxing County People's Hospital
Feb 14, 2023
Colorectal Cancer, Peritoneal Metastases Trial in Eindhoven, Rotterdam (Irinotecan, FOLFOX regimen, Bevacizumab)
Recruiting
- Colorectal Cancer
- Peritoneal Metastases
- Irinotecan
- +2 more
-
Eindhoven, Netherlands
- +1 more
Aug 15, 2023
Carcinoma Trial in Taoyuan City
Recruiting
- Carcinoma
-
Taoyuan City, TaiwanChang Gung Memorial Hospital
Feb 21, 2023
Stomach Tumors, Paclitaxel, Peritoneal Metastases Trial in Seoul (Paclitaxel)
Recruiting
- Stomach Neoplasms
- +2 more
-
Seoul, Korea, Republic ofGastric cancer center, Seoul St. Mary's Hospital
Jul 1, 2021
Single-Cell Transcriptomics of Peritoneal Microenvironment of
Recruiting
- Peritoneal Metastases
- CRC+HIPEC
-
Ghent, Oost-Vlaanderen, BelgiumUZ Ghent
Dec 22, 2022
Appendix Cancer, Colorectal Cancer Trial in United States (Cytoreductive Surgery, HIPEC with Mitomycin-C, EPIC with FUDR and
Recruiting
- Appendix Cancer
- Colorectal Cancer
- Cytoreductive Surgery
- +2 more
-
Miami, Florida
- +8 more
Jan 12, 2023